British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women.
FDA approves Glaxo's cervical cancer vaccineCourtesy Topix - Business News Sun, 10/18/2009 - 07:09
British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women. Related itemsGlaxo Pays $750 Million Fine for Tainted Products
Glaxo defends safety of weight loss drug alli
GlaxoSmithKline says HPV vaccine worked in study
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
Uniden TRU9496 2-Line Corded/Cordless Digital...
|
Popular by tags WeekMonth |
Post new comment